Priser
Platform
Blog
Om os
Download
Quest PharmaTech
Quest PharmaTech
TSX Venture Exchange
0

Om

Quest Pharmatech Inc. is a biopharmaceutical company focused on developing and commercializing innovative oncology therapies. The company's primary mission is to enhance the efficacy and safety of cancer treatments through novel approaches, leveraging its expertise in immunotherapy and photodynamic therapy. Quest Pharmatech Inc. specializes in creating next-generation biologic drugs targeting various forms of cancer, aiming to improve patient outcomes through advanced treatment modalities. The firm is actively engaged in research and development efforts, collaborating with academic institutions and other industry players to bring innovative therapies to market. Quest Pharmatech Inc.'s initiatives are crucial for addressing unmet medical needs in oncology and have positioned it as a significant player in the healthcare sector. By targeting specific cancer types and exploring new therapeutic pathways, the company contributes to the dynamic field of cancer treatment and aims to make a meaningful impact on global healthcare challenges.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I QUEST PHARMATECH MED ENDAVU: Køb Quest PharmaTech ($QPT) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Quest PharmaTech, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerQPT
Land
Canada
Hjemmesidequestpharmatech.com
SektorSundhed
IndustriBioteknologi

Udbytter

0,22CAD
'00
0,22CAD
'01
0,22CAD
'02
0,22CAD
'03
0,22CAD
'04
0,17CAD
'05
Ex-udbytte-dato21. jul. 2005